Aorta-CAD

by Imagen Technologies  · Based in United States →Improving the accessibility, accuracy, and immediacy of frontline diagnostic imaging.
Cardiology Internal Medicine Radiology

Contact for pricing
Regulatory Status Disclosed

Overview

Aorta-CAD, developed by Imagen Technologies, is an FDA-cleared, cloud-based, software-only medical device leveraging deep learning to assist physicians in detecting findings on chest X-rays suggestive of Aortic Atherosclerosis and Aortic Ectasia. It is designed to be a concurrent reading aid for physicians, including radiologists and Primary Care Physicians (PCPs), by identifying and highlighting suspicious regions of interest (ROIs) with annotations on the X-ray image via an overlay.

The device seamlessly integrates into existing X-ray reading workflows without requiring new Picture Archiving and Communication System (PACS) technology or costly re-training of physicians. Clinical studies have demonstrated its effectiveness, showing a 62% relative reduction in misses for aortic calcification suggestive of Aortic Atherosclerosis and a 35% relative reduction in misses for dilated aorta suggestive of Aortic Ectasia. Overall, 96% of physicians showed improvement when assisted by Aorta-CAD. Aorta-CAD is part of Imagen’s Diagnostics as a Service (DaaS) platform, aiming to improve patient outcomes through earlier and more accurate diagnoses.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Detects and highlights radiographic findings suggestive of Aortic Atherosclerosis and Aortic Ectasia
  • Cloud-based, software-only medical device
  • Utilizes deep learning algorithms for analysis
  • Seamlessly integrates into existing X-ray reading workflows
  • Creates annotations via an overlay that can be toggled on/off
  • Assists physicians (radiologists and PCPs) in interpreting chest X-rays
  • Demonstrated 62% relative reduction in misses for aortic calcification in clinical study
  • Demonstrated 35% relative reduction in misses for dilated aorta in clinical study
  • Part of Imagen's Diagnostics as a Service (DaaS) platform
  • Indicated for adults only

Use Cases

  • Early detection of Aortic Atherosclerosis
  • Early detection of Aortic Ectasia
  • Assisting physicians in interpreting chest X-rays
  • Improving diagnostic accuracy and reducing misinterpretation rates
  • Enhancing patient treatment plans and care
  • Identifying previously undiagnosed chronic ailments

What Physicians Need to Know

Heart Failure Risk Prediction
By identifying findings like aortic calcifications and dilated aorta on chest X-rays, Aorta-CAD can indirectly contribute to heart failure risk assessment, as these indicators are associated with increased cardiovascular risk.
Real-Time Alert Capability
The tool provides real-time annotations and highlights directly on chest X-ray images, drawing the physician's attention to findings suggestive of aortic atherosclerosis and aortic ectasia. This overlay can be toggled off as needed.
AHA/ACC Guideline Alignment
Aorta-CAD is an FDA-cleared computer-assisted detection (CADe) device, indicating it meets regulatory standards. Its function in identifying aortic conditions supports early detection and risk stratification, aligning with general cardiovascular care principles.
Physician Tip

Aorta-CAD serves as an assistive tool to enhance the detection of aortic atherosclerosis and ectasia on chest X-rays, particularly for primary care physicians and radiologists. Its deep learning algorithms provide a consistent and repeatable process for reviewing the cardiac silhouette. Physicians should consider follow-up imaging, such as CT or MRI, for patients with positive findings to further characterize the detected conditions. The tool's ability to highlight subtle findings can aid in earlier identification of chronic ailments, potentially improving patient outcomes and guiding treatment plans.

Aorta-CAD is a cloud-based, software-only medical device designed for seamless integration into existing X-ray reading workflows. It does not require new Picture Archiving and Communication System (PACS) technology or costly re-training, making it easily adoptable within current clinical environments.

Details

Category Cardiology AI, Radiology & Imaging AI
Pricing Contact for pricing Contact Imagen Technologies directly for pricing information.
DeploymentCloud-based
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

Aorta-CAD received U.S. FDA 510(k) clearance (K213353) on September 20, 2022, as a computer-assisted detection (CADe) software device for analyzing chest radiographs for findings suggestive of Aortic Atherosclerosis or Aortic Ectasia.

Integrations
EHR Not specified
Specialties Cardiology, Internal Medicine, Radiology

What the Web Says

Aorta-CAD is an FDA-cleared, cloud-based AI software designed to assist physicians in detecting findings on chest X-rays suggestive of Aortic Atherosclerosis and Aortic Ectasia. Clinical studies indicate that the software significantly reduces missed diagnoses for these conditions, with 96% of physicians showing improvement when assisted by Aorta-CAD. It integrates seamlessly into existing X-ray reading workflows without requiring new PACS technology or costly retraining.

Overall: Positive

Strengths

  • Significantly reduces missed diagnoses for aortic calcification (62% relative reduction) and dilated aorta (35% relative reduction).
  • 96% of physicians showed improvement when using Aorta-CAD.
  • Cloud-based and software-only, making it easily accessible.
  • Integrates into current chest X-ray workflows without needing new PACS technology or extensive retraining.
  • Aids in earlier and better detection and treatment of chronic diseases.
  • Helps physicians handle higher caseloads and deliver faster turnaround times, potentially preventing burnout.

Limitations

  • No specific cons were found in the provided search results from physicians, healthcare IT, tech reviewers, Reddit, G2, or Capterra.
  • General CAD software can have a steep learning curve and be costly, though Aorta-CAD's specific cost isn't mentioned.

Based on reviews from: Imagen, PRNewswire, Applied Radiology, AuntMinnie, DAIC, accessdata.fda.gov

Last updated: 2026-07-20

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Aorta-CAD

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

PR Newswire
Imagen Technologies Announces FDA Clearance of Aorta-CAD
Imagen Technologies received FDA 510(k) clearance for its Aorta-CAD device, an AI-powered software that assists physicians in detecting findings on chest X-rays suggestive of Aortic Atherosclerosis and Aortic Ectasia. The device is part of Imagen's Diagnostics as a Service (DaaS) platform and aims to improve early detection and treatment of chronic aortic conditions.
2022-12
Medical Device Network
Imagen Technologies' Aorta-CAD device receives FDA 510(k) clearance
Imagen Technologies has secured FDA 510(k) clearance for its Aorta-CAD, a computer-assisted detection (CADe) device that uses deep learning to identify findings related to aortic atherosclerosis and aortic ectasia on chest X-rays. Clinical trials showed a 62% relative reduction in misses for aortic calcification and a 35% relative reduction in misses for dilated aorta.
2022-12
AuntMinnie
FDA clears Imagen's computer-aided detection device for chest x-rays | AuntMinnie
Imagen Technologies' Aorta-CAD software, a cloud-based AI tool, has received FDA clearance to help physicians identify signs of aortic atherosclerosis and aortic ectasia on chest X-rays. The software is integrated into the company's DaaS platform and has shown to reduce missed aortic calcifications by 62% and dilated aortas by 35%.
2022-12
Applied Radiology
Imagen Gets FDA Nod for Aorta-CAD - Applied Radiology
Imagen Technologies has received FDA 510(k) clearance for its Aorta-CAD, a cloud-based, software-only medical device utilizing deep learning to detect and highlight findings suggestive of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays. The device aims to help primary care physicians improve early detection and treatment, integrating seamlessly into existing workflows.
2022-12
Diagnostic and Interventional Cardiology (DAIC)
Imagen Technologies Announces FDA Clearance of Aorta-CAD | DAIC
Imagen Technologies' Aorta-CAD, an AI-powered computer-assisted detection device, has received FDA 510(k) clearance to aid physicians in detecting findings on chest X-rays indicative of Aortic Atherosclerosis and Aortic Ectasia. This marks Imagen's fourth FDA clearance and expands its Diagnostics as a Service platform.
2022-12
Imagen Technologies
Newsroom - Imagen
Imagen Technologies announced the FDA 510(k) clearance of its Aorta-CAD computer-assisted detection device on December 5, 2022. This new AI device expands the capabilities of their Diagnostics as a Service platform, aiming to improve the detection of aortic atherosclerosis and aortic ectasia.
2022-12
IMARC Group
U.S. Computer-Aided Detection (CAD) Market Size & Forecast 2033
In December 2022, Imagen Technologies, Inc. received FDA clearance for its Aorta-CAD device, a cloud-based, software-only medical device using deep learning to detect findings on chest X-rays suggestive of Aortic Atherosclerosis and Aortic Ectasia. This contributes to the growing U.S. Computer-Aided Detection (CAD) Market, which is projected to reach USD 1,656.7 million by 2033.
2022-12
Journal of the American College of Cardiology
Artificial intelligence in cardiac amyloidosis: Expert insights on adoption challenges, opportunities and best practices for developing
A 2025 article discussing artificial intelligence in cardiac amyloidosis lists Imagen Technologies' Aorta-CAD (K213353) as an FDA-cleared AI tool for detecting Aortic Atherosclerosis on X-rays in 2022. The article highlights the importance of seamless integration of AI tools into hospital systems to minimize disruption.
2025-05

Videos

Product demos, reviews, and walkthroughs for Aorta-CAD.

View all on YouTube

Frequently Asked Questions

Aorta-CAD is designed to integrate seamlessly with existing PACS and EMR platforms, often using standard protocols like DICOM. It functions as a concurrent reading aid, providing automated analysis and highlighting findings suggestive of Aortic Atherosclerosis and Aortic Ectasia on chest X-rays within the physician's existing workflow, aiming to enhance efficiency without requiring new PACS technology or costly re-training.
Aorta-CAD has received U.S. Food and Drug Administration (FDA) 510(k) clearance as a computer-assisted detection (CADe) device. While specific details on CE Mark were not found, AI solutions in healthcare generally employ robust encryption, access controls, and de-identification protocols to comply with patient data privacy regulations like HIPAA and GDPR.
Traditional methods for detecting aortic conditions often involve manual interpretation of imaging studies like CT or MRI by expert radiologists and cardiologists, with CT being the gold standard for aortic diameter measurement. Aorta-CAD is intended as a concurrent reading aid to assist physicians in detecting findings on chest X-rays suggestive of Aortic Atherosclerosis and Aortic Ectasia, not to replace the physician or other diagnostic testing. Clinical trials have shown that physicians, when assisted by Aorta-CAD, experienced a 62% relative reduction in misses for aortic calcification and a 35% relative reduction in misses for dilated aorta, with 96% of physicians showing improvement.
The specific pricing model for Aorta-CAD (e.g., subscription, per-study, or capital expenditure) is not explicitly detailed in the provided search results. However, AI solutions in healthcare often offer flexible pricing structures. While direct reimbursement codes for AI-assisted interpretation are still evolving, the system aims to support existing diagnostic codes by enhancing efficiency and accuracy.
Aorta-CAD is indicated for adults only and analyzes chest radiograph studies for suspicious regions. While designed for high accuracy, AI models can have limitations such as performance variations with severe image artifacts, unusual anatomies, or specific rare pathologies not extensively represented in training data. The clinical trial for Aorta-CAD reported a 62% relative reduction in misses for aortic calcification and a 35% relative reduction in misses for dilated aorta.
While the exact frequency of updates for Aorta-CAD is not specified, AI solutions generally undergo regular updates to enhance features, improve model performance, and address identified issues. These updates are typically deployed through secure, validated channels, and the development roadmap often incorporates feedback from clinical users and new research findings to continuously refine capabilities.

Related Tools

Cardiomatics
Cardiomatics
Cardiology AI
Cardiomatics is a cloud-based, AI-powered software for analyzing ambulatory (Holter) ECG tests, using clinically validated algorithms to provide accurate and high-quality results for cardiac diagnostics. It aims to streamline ECG analysis, reduce interpretation time, and improve diagnostic accuracy for various heart conditions.
SafeBeat Rx App
SafeBeat Rx, Inc.
Cardiology AI
An AI application designed to support safe pharmacological treatment and monitoring for cardiac arrhythmias.
PreemptiveAI Clinical SDK
Measure Labs, Inc. (Dba Preemptiveai, Inc.)
Cardiology AI
A clinical software development kit using AI to model and predict cardiovascular health metrics, aiming to shift healthcare from reactive to proactive by providing early health risk signals.
Clarius Ejection Fraction AI
Clarius Mobile Health Corp.
Cardiology AI
Clarius Ejection Fraction AI is an AI-powered ultrasound tool for automated left ventricular ejection fraction calculation, integrated into the Clarius Ultrasound App for real-time cardiac assessments.
Automated Aortic Stenosis Software (AutoAS)
Multiple companies are developing Automated Aortic Stenosis Software (AutoAS) or similar AI-powered solutions. Notable ones include iCardio.ai, Us2.ai, AccurKardia, HeartSciences Inc., and Echo IQ.
Cardiology AI
Automated Aortic Stenosis Software (AutoAS) is an ultrasound application by GE Medical Systems that provides automated assessment of aortic stenosis to enhance diagnostic efficiency and consistency.
ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm
Anumana
Cardiology AI
An AI algorithm that analyzes standard 12-lead ECG recordings to detect signs of pulmonary hypertension, aiming for earlier diagnosis and improved patient outcomes.

See all Cardiology AI tools →

More from Imagen Technologies

Chest-CAD
Imagen Technologies
Clinical Decision Support & Reference
Chest-CAD by Imagen Technologies is an FDA-cleared AI software that detects, categorizes, and localizes suspicious regions on adult chest X-rays, shown to reduce diagnostic errors by 40%.
FractureDetect (FX)
Imagen Technologies
Radiology & Imaging AI
FractureDetect (FX) by Imagen Technologies is an FDA-cleared AI-powered computer-assisted detection and diagnosis (CAD) software device designed to assist clinicians in detecting hard-to-spot fractures on musculoskeletal radiographs in adults, thereby improving diagnostic accuracy and reducing missed fractures.
Imagen OsteoDetect
Imagen Technologies
Clinical Decision Support & Reference
Imagen OsteoDetect is an FDA-cleared AI-driven software that assists clinicians in detecting distal radius fractures on adult wrist X-rays, enhancing diagnostic accuracy and speed.
Lung-CAD
Imagen Technologies
Oncology AI
Imagen Technologies provides FDA-cleared, AI-enabled diagnostic imaging software, including Lung-CAD, to enhance diagnostic quality, efficiency, and patient care in radiology and primary care settings.

View company profile →

Suggest an Edit → | Last Verified: 2026-04-20 | First Added: 2026-04-20
AI Tool Finder
AI-powered search. Results may not be comprehensive.